To determine whether the damage observed in the model was caused by activation of TLR4 signaling pathways, the TLR4 inhibitor, TAK-242, was used with fluoxetine serving as the positive control to assess neuronal injury in the environment of hypertension-related depression. Here, TLR4 is linked to depressive disorder.